FDA Inspection 1245789 — Osteotech, Inc.
The FDA completed an inspection of Osteotech, Inc. on June 18, 2024 in Eatontown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 18, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Eatontown, NJ (United States)